About
Hbm Holdings Ltd (HK:2142) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 9 2026
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis
Feb 4 2026
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results
Jan 19 2026
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
Jan 12 2026
Control Devices Acquires Sherwood Valve
Dec 29 2025
Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
Financials
Revenue
HK$157.98 M
Market Cap
HK$12.09 B
P/E Ratio
19.55
EPS
0.09